Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Expert Recommendations from The Korean Society for

In Seok Jeong1, Woong-Han Kim2, Jong Hyun Baek3

  • 1Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.

Insights

Extracorporeal membrane oxygenation (ECMO) may aid COVID-19 patients, but evidence is limited. This study reviews literature and Korean registry data to assess ECMO efficacy and provide expert recommendations for its use in treating coronavirus disease 2019.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Cardiopulmonary Support

Background:

  • The COVID-19 pandemic has seen a rapid increase in cases and deaths globally.
  • Extracorporeal membrane oxygenation (ECMO) is a life support technology, but its efficacy for COVID-19 remains debated among experts.
  • Existing ECMO guidelines may not fully align with the Korean medical system and real-world practices.

Purpose of the Study:

  • To evaluate the efficacy of ECMO in treating patients with COVID-19.
  • To develop expert recommendations for ECMO application in the context of the Korean healthcare system.
  • To bridge the gap between existing literature and practical clinical decision-making for ECMO in COVID-19.

Main Methods:

  • Systematic literature review of studies on ECMO for COVID-19 patients.
  • Analysis of data from the Korean COVID-19 ECMO registry.
  • Synthesis of findings to formulate expert recommendations.

Main Results:

  • Evidence on ECMO efficacy for COVID-19 is still evolving, with varied outcomes reported in the literature.
  • Korean registry data provides insights into real-world application and outcomes of ECMO in COVID-19 patients.
  • Specific challenges and considerations for ECMO implementation within the Korean medical system were identified.

Conclusions:

  • Further research is needed to solidify the role of ECMO in COVID-19 management.
  • Tailored recommendations based on national data are crucial for optimizing ECMO use in Korea.
  • A balanced approach considering evidence and local context is essential for ECMO decision-making in COVID-19.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned under...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...